Oxford Metrics PLC header image

Oxford Metrics PLC

OMG

Equity

ISIN GB0030312788 / Valor 1222541

LSE London Stock Exchange, SETS (2026-04-02)
GBP 0.44-1.11%

Oxford Metrics PLC
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Oxford Metrics PLC, established in 1984, specializes in providing advanced motion capture systems and smart sensor technologies that bridge the physical and digital worlds. The company is renowned for its Vicon motion capture systems, which are widely used across various industries including automotive, education, electronics, entertainment, healthcare, pharmaceuticals, research, and sports. With a customer base exceeding 10,000 across more than 70 countries, Oxford Metrics serves prominent clients such as Industrial Light & Magic, Epic Games, EA Sports, Boeing, Airbus, and NASA. These clients utilize Vicon systems for applications ranging from creating visual effects and virtual production in entertainment to advancing ergonomics, engineering, and UAV research in industrial and academic settings. The company has a history of growth through innovation and strategic acquisitions, continually expanding its technological capabilities and market reach.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (19.03.2026):

Oxford Metrics PLC — Q4 2025 (full-year FY25 ended 30 September 2025): the Group reported revenue of £44.8m (up 8% year‑on‑year) and adjusted EBIT of £2.2m (up 29%). Adjusted basic EPS fell to 1.55p (FY24: 3.01p) while statutory basic EPS was a loss of 0.55p. Motion Capture revenue fell to £32.0m but in‑year order intake rose 21% to £34.8m; Smart Manufacturing grew to £12.8m (up 341%, 38% organic) supported by two acquisitions. Operating cash generation before tax improved to £6.7m and the Group returned £12.5m to shareholders (buybacks and dividends); cash and fixed-term deposits were £37.3m at year end. Strategic progress included the Markerless Motion Capture launch and consolidation of Smart Manufacturing capabilities.

Revenue and divisional mix

Group revenue £44.8m (+8%). Motion Capture: £32.0m (down from £38.6m) — opening order book normalised to £1.0m (FY24: £11.5m) but in‑year order intake +21% to £34.8m. Smart Manufacturing: £12.8m (up 341%), including two acquisitions (The Sempre Group and Amber Optix) and 38% organic growth, now ~29% of Group revenue.

Profitability and adjusted measures

Adjusted EBIT £2.2m (+29%). Adjusted basic EPS 1.55p (‑49% vs FY24) driven in part by lower net finance income; statutory profit before tax £0.1m and statutory basic EPS a loss of 0.55p. Adjusted measures exclude items such as share‑based payments, acquisition amortisation, restructuring/IMU closure costs and a £0.75m impairment of development costs.

Cash, balance sheet and returns to shareholders

Cash and fixed‑term deposits £37.3m (down 26% from £50.7m). Operating cash generation before tax improved to £6.7m (FY24: £0.3m) from better working capital and inventory optimisation. The Group returned c.£12.5m to shareholders via dividends (£4.2m) and on‑market buybacks (c.£8.3m deployed by year end).

Strategic priorities and product launches

Markerless Motion Capture was launched (initially into entertainment) to expand software/recurring revenue opportunities alongside marker‑based systems. The Smart Manufacturing capability was strengthened by acquiring Sempre and Amber Optix to accelerate projects‑to‑product conversion, improve margins and broaden addressable markets.

Operational progress and cost discipline

Adjusted EBIT improvement supported by higher Smart Manufacturing volumes, continued high margins in Motion Capture and cost discipline including prior-year cost savings (~£1.2m annualised). Inventory was reduced to £5.9m and trade receivables rose with stronger Q4 trading and acquisitions.

Notable one‑offs and accounting items

FY25 included £0.75m impairment of capitalised development costs (related to Markerless development superseded by release), acquisition‑related costs and amortisation of acquired intangibles (£0.8m). The Board is also proposing to change the accounting reference date to 31 December (extending the next year to 31 Dec 2026) to better balance period seasonality.

Current trading and outlook

Q1 FY26 trading is reported in line with Board expectations. Management is refocusing Motion Capture resources on stronger geographies (APAC, EMEAI), unifying Smart Manufacturing under one structure to improve order‑to‑revenue conversion, and targeting disciplined organic investment plus selective small bolt‑on M&A. A refined three‑year strategy will be set out in H1 FY26.

Summarized from source with an LLMView Source

Key figures

-15.7%1Y
-55.0%3Y
-52.9%5Y

Performance

39.5%1Y
37.1%3Y
36.2%5Y

Volatility

Market cap

68 M

Market cap (USD)

Daily traded volume (Shares)

167,795

Daily traded volume (Shares)

1 day high/low

0.56 / 0.55

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

CyberArk Software Ltd
CyberArk Software Ltd CyberArk Software Ltd Valor: 24786540
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 408.85
Workiva Inc
Workiva Inc Workiva Inc Valor: 25831452
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.49%USD 60.00
Cytokinetics Inc
Cytokinetics Inc Cytokinetics Inc Valor: 21533074
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.18%USD 66.73
Verbio SE
Verbio SE Verbio SE Valor: 2731349
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
7.36%EUR 43.48
Huber + Suhner AG
Huber + Suhner AG Huber + Suhner AG Valor: 3038073
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.54%CHF 184.60
Acadia Pharmaceuticals Inc
Acadia Pharmaceuticals Inc Acadia Pharmaceuticals Inc Valor: 1184425
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.54%USD 22.20
Kainos Group PLC
Kainos Group PLC Kainos Group PLC Valor: 28842999
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.13%GBP 7.61
Salesforce Inc
Salesforce Inc Salesforce Inc Valor: 1755645
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.50%USD 187.18
Parsons Corporation
Parsons Corporation Parsons Corporation Valor: 47481760
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.23%USD 56.32
Innodata Inc.
Innodata Inc. Innodata Inc. Valor: 856023
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.00%USD 38.47